Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.0K
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
2.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent Fasting and Risk of Diabetic Retinopathy: Retrospective Data from the National Health and Nutrition Examination Survey.

Nutrients·2026
Same author

Confinement and Interface Effects on Radiolysis in Liquid-Phase TEM Probed by Palladium Nanocrystal Etching.

Nano letters·2026
Same author

Integrating habitat suitability, socioeconomics, and infrastructure to assess global biological invasion risk under climate change: A case study of the rice stem borer, Chilo suppressalis.

Pest management science·2026
Same author

Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes: a population-based cohort study.

BMC medicine·2026
Same author

Differential Responses and Temporal Lags of Heterotrophic and Autotrophic Respiration to Plant Activity in a Forest Ecosystem.

Plants (Basel, Switzerland)·2026
Same author

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real-World Observational Study.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: May 4, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

2.7K

Exploiting tumor cell senescence in anticancer therapy.

Minyoung Lee1, Jae-Seon Lee2

  • 1Research Center for Radio-senescence, Korea Institute of Radiological and Medical Sciences, Seoul 139-706, Korea.

BMB Reports
|January 14, 2014
PubMed
Summary

Cellular senescence, a state of irreversible cell-cycle arrest, plays a dual role in aging and cancer. Understanding senescence mechanisms is key to developing novel anticancer therapies.

More Related Videos

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.5K
A Sensitive Method to Quantify Senescent Cancer Cells
09:18

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

20.4K

Related Experiment Videos

Last Updated: May 4, 2026

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

2.7K
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
07:39

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

Published on: June 28, 2019

23.5K
A Sensitive Method to Quantify Senescent Cancer Cells
09:18

A Sensitive Method to Quantify Senescent Cancer Cells

Published on: August 2, 2013

20.4K

Area of Science:

  • Gerontology
  • Oncology
  • Cell Biology

Background:

  • Cellular senescence is a fundamental aging process involving irreversible cell-cycle arrest.
  • It can be triggered by telomere attrition (replicative senescence) or external stressors like DNA damage (stress-induced premature senescence).
  • Senescence acts as a tumor suppressor but its secretory phenotype can also promote cancer progression.

Purpose of the Study:

  • To review the molecular mechanisms, functions, and clinical applications of cellular senescence in anticancer therapy.
  • To highlight the role of senescence in cancer treatment outcomes.
  • To explore how senescence can be leveraged for novel therapeutic strategies.

Main Methods:

  • This review synthesizes current research on cellular senescence.
  • It examines the molecular pathways involved in senescence induction and function.
  • The review discusses the impact of senescence on cancer development and treatment.

Main Results:

  • Cellular senescence is a critical factor in aging and cancer biology.
  • Conventional cancer treatments like chemotherapy and radiotherapy can induce premature senescence.
  • Senescence can influence tumor suppression and treatment resistance.
  • The senescence-associated secretory phenotype has complex effects on neighboring cells.

Conclusions:

  • Understanding cancer cell senescence is crucial for developing innovative anticancer therapies.
  • Targeting senescence pathways may enhance the efficacy of existing cancer treatments.
  • Further research into senescence mechanisms can lead to improved therapeutic strategies.